6 results match your criteria: "Centre of Liver and Digestive Disorders[Affiliation]"
Multicentre European study of double balloon enteroscopy for small bowel pathology in patients with cardiovascular disease.
Expert Rev Gastroenterol Hepatol
May 2017
a Gastroenterology , Royal Hallamshire Hospital, Sheffield Teaching Hospitals, Sheffield , UK .
Small bowel capsule endoscopy and portal hypertensive enteropathy in cirrhotic patients: results from a tertiary referral centre.
Ann Hepatol
January 2017
Centre of Liver and Digestive Disorders, Royal Infirmary of Edinburgh. Edinburgh, United Kingdom.
Background And Rationale: Portal hypertensive enteropathy (PHE) remains difficult to diagnose in patients with cirrhosis and portal hypertension. Limited test choices exist for the inspection of the small bowel in these patients. Small bowel capsule endoscopy (SBCE) is ideal in this situation but rarely performed.
View Article and Find Full Text PDFAngioectasias on the major and accessory duodenal papillae; a unique cause of recurrent bleed in a patient with von Willebrand's disease.
BMJ Case Rep
November 2015
Centre of Liver and Digestive Disorders, Royal Infirmary of Edinburgh, Edinburgh, UK.
(1)H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy.
World J Hepatol
June 2015
Konstantinos John Dabos, John Nicholas Plevris, Peter Clive Hayes, Centre of Liver and Digestive Disorders, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, Scotland, United Kingdom.
Aim: To identify plasma metabolites used as biomarkers in order to distinguish cirrhotics from controls and encephalopathics.
Methods: A clinical study involving stable cirrhotic patients with and without overt hepatic encephalopathy was designed. A control group of healthy volunteers was used.
Portal hypertensive enteropathy & capsule endoscopy.
Ann Hepatol
September 2009
Centre of Liver and Digestive Disorders Royal Infirmary of Edinburgh. 51 Little France Crescent, Edinburgh, EH164SA.
Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure.
Transplantation
January 2004
Centre of Liver and Digestive Disorders, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
Background: Fulminant hepatic failure (FHF) is associated with major metabolic disturbances, the onset and severity of which can predict clinical outcome. This study uses admission blood samples to identify early biochemical markers of clinical outcome in patients with non-paracetamol-induced FHF.
Patients And Methods: Fifty-nine patients admitted to the Scottish Liver Transplant Unit with non-paracetamol-induced FHF were studied.